Baldwin Brothers Inc. MA increased its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 35.8% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 3,830 shares of the health services provider’s stock after purchasing an additional 1,010 shares during the period. Baldwin Brothers Inc. MA’s holdings in Teladoc Health were worth $840,000 as of its most recent filing with the SEC.
A number of other institutional investors have also bought and sold shares of the stock. IFM Investors Pty Ltd grew its holdings in Teladoc Health by 9.5% during the third quarter. IFM Investors Pty Ltd now owns 5,767 shares of the health services provider’s stock worth $1,264,000 after purchasing an additional 499 shares during the period. First Citizens Bank & Trust Co. bought a new stake in shares of Teladoc Health during the third quarter worth approximately $1,366,000. Teamwork Financial Advisors LLC boosted its holdings in shares of Teladoc Health by 133.7% during the third quarter. Teamwork Financial Advisors LLC now owns 2,501 shares of the health services provider’s stock worth $548,000 after acquiring an additional 1,431 shares during the period. Ford Financial Group LLC boosted its holdings in shares of Teladoc Health by 28.6% during the third quarter. Ford Financial Group LLC now owns 5,840 shares of the health services provider’s stock worth $1,280,000 after acquiring an additional 1,300 shares during the period. Finally, Vigilare Wealth Management bought a new stake in shares of Teladoc Health during the third quarter worth approximately $267,000. Institutional investors and hedge funds own 87.39% of the company’s stock.
Shares of NYSE TDOC traded down $3.06 during midday trading on Friday, reaching $221.29. 1,279,276 shares of the company were exchanged, compared to its average volume of 3,148,213. The stock’s 50-day moving average price is $210.62 and its 200-day moving average price is $194.81. The stock has a market cap of $18.36 billion, a P/E ratio of -172.88 and a beta of 0.30. Teladoc Health, Inc. has a one year low of $66.23 and a one year high of $253.00. The company has a quick ratio of 11.36, a current ratio of 11.36 and a debt-to-equity ratio of 0.73.
Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, July 29th. The health services provider reported ($0.34) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.11). Teladoc Health had a negative return on equity of 9.54% and a negative net margin of 13.22%. The company had revenue of $241.03 million for the quarter, compared to the consensus estimate of $220.49 million. During the same period in the previous year, the firm posted ($0.41) EPS. The business’s quarterly revenue was up 85.0% compared to the same quarter last year. On average, equities research analysts anticipate that Teladoc Health, Inc. will post -1.4 EPS for the current year.
TDOC has been the subject of a number of research analyst reports. Barclays boosted their price objective on Teladoc Health from $200.00 to $230.00 and gave the stock an “equal weight” rating in a report on Thursday, July 30th. Wells Fargo & Company boosted their price objective on Teladoc Health from $135.00 to $175.00 in a report on Thursday, July 30th. Argus initiated coverage on shares of Teladoc Health in a research report on Monday, July 13th. They issued a “buy” rating and a $280.00 price target for the company. Citigroup initiated coverage on shares of Teladoc Health in a research report on Tuesday, July 14th. They issued a “buy” rating and a $275.00 price target for the company. Finally, Stifel Nicolaus lifted their price target on shares of Teladoc Health from $144.00 to $205.00 and gave the company a “hold” rating in a research report on Thursday, July 30th. Twelve equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $213.07.
In other Teladoc Health news, Director William H. Frist sold 740 shares of the company’s stock in a transaction on Friday, July 24th. The shares were sold at an average price of $214.71, for a total transaction of $158,885.40. Following the sale, the director now owns 6,158 shares of the company’s stock, valued at $1,322,184.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Andrew Turitz sold 717 shares of the company’s stock in a transaction on Friday, October 2nd. The shares were sold at an average price of $225.00, for a total transaction of $161,325.00. Following the sale, the senior vice president now directly owns 4,732 shares in the company, valued at approximately $1,064,700. The disclosure for this sale can be found here. In the last three months, insiders sold 83,555 shares of company stock worth $19,163,813. 3.42% of the stock is currently owned by insiders.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services on a business-to-business basis in the United States and internationally. It covers various clinical conditions, including non-critical, episodic care, chronic, and complicated cases like cancer and congestive heart failure, as well as offers telehealth solutions, expert medical services, behavioral health solutions, guidance and support, and platform and program services.
See Also: Hedge Funds – Risk or Reward?
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.